These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31679899)

  • 1. Indications of plasma exchanges in combination with intravenous immunoglobulins or therapeutic monoclonal antibodies. How to combine them?
    Vendramin C; Scully M
    Presse Med; 2019 Nov; 48(11 Pt 2):354-359. PubMed ID: 31679899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchanges. A still effective treatment.
    Guillevin L
    Presse Med; 2019 Nov; 48(11 Pt 2):317-318. PubMed ID: 31806125
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoglobulins or plasma exchange? Synchronization of plasma exchange and intravenous polyvalent immunoglobulins. A consecutive study of 11 patients].
    Bussel A; Boulechfar H; Naim R
    Ann Med Interne (Paris); 1993; 144(8):532-8. PubMed ID: 8179243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Sturzenegger T
    Ther Apher; 2001 Jun; 5(3):186-92. PubMed ID: 11467755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
    Lehmann HC; Hartung HP
    J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Rieben R
    Ann Med Interne (Paris); 1994; 145(5):287-92. PubMed ID: 7985933
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can we do without intravenous polyclonal immunoglobines (IVIg)?].
    Gary-Crosier F; Nydegger U; Villard J
    Rev Med Suisse; 2009 Apr; 5(199):819-22. PubMed ID: 19441747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for autoimmune autonomic ganglionopathy.
    Iodice V; Kimpinski K; Vernino S; Sandroni P; Low PA
    Auton Neurosci; 2009 Mar; 146(1-2):22-5. PubMed ID: 19056323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease.
    Thornton CA; Griggs RC
    Ann Neurol; 1994 Mar; 35(3):260-8. PubMed ID: 8122878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: the concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange.
    Baron BW; Martin MS; Sucharetza BS; Jeon H; Baron JM
    J Clin Apher; 2001; 16(4):179-85. PubMed ID: 11835414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
    Bazin R; Lemieux R; Tremblay T
    Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.
    Perlmutter SJ; Leitman SF; Garvey MA; Hamburger S; Feldman E; Leonard HL; Swedo SE
    Lancet; 1999 Oct; 354(9185):1153-8. PubMed ID: 10513708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies.
    Comi G; Nemni R; Amadio S; Galardi G; Leocani L
    Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catastrophic antiphospholipid syndrome: The current management approach.
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):239-249. PubMed ID: 27886797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.
    Kaveri SV; Dietrich G; Hurez V; Kazatchkine MD
    Clin Exp Immunol; 1991 Nov; 86(2):192-8. PubMed ID: 1934588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The establishment of in-house neurology driven therapeutic plasma exchange infrastructure in a resource-limited public hospital in Malaysia: Adopting and integrating evidenced-based health care technology through time.
    Viswanathan S; Hiew FL
    J Clin Apher; 2019 Aug; 34(4):434-444. PubMed ID: 30829434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.